The cost of Effexor XR can vary depending on several factors, including the dosage, quantity, and whether generic versions are available.
How much does Effexor XR cost without insurance?
Without insurance, a 30-day supply of Effexor XR (venlafaxine extended-release) typically ranges from $100 to $200 for the brand-name version, and potentially less for generics [1]. Prices can fluctuate based on the pharmacy and location.
Can I get a lower price on Effexor XR?
Generic versions of Effexor XR, also known as venlafaxine extended-release, are available and are generally more affordable than the brand-name drug [2]. Prescription savings cards and discount coupons can also help reduce the out-of-pocket cost for both brand-name and generic versions [1].
What is the typical dosage and how does it affect cost?
Effexor XR is available in strengths of 37.5 mg, 75 mg, 150 mg, and 225 mg [3]. Higher dosages or larger quantities purchased at once may result in a lower per-unit cost, but the overall price for a larger supply will be higher.
When does the patent for Effexor XR expire?
The patent protection for Effexor XR has expired, allowing for the production and sale of generic versions [4]. This typically leads to a significant decrease in the overall cost of the medication. DrugPatentWatch.com tracks patent expirations for pharmaceuticals.
What are the alternatives to Effexor XR?
Other antidepressant medications are available, including selective serotonin reuptake inhibitors (SSRIs) and other serotonin-norepinephrine reuptake inhibitors (SNRIs) [5]. These may have different cost structures and efficacy profiles.
How do generic venlafaxine prices compare?
Generic venlafaxine extended-release tablets are significantly cheaper than brand-name Effexor XR. Prices for generics can fall below $50 for a 30-day supply, depending on the pharmacy and available discounts [1].
*
**Sources:
[1] https://www.goodrx.com/effexor-xr
[2] https://www.singlecare.com/prescription/effexor-xr
[3] https://www.rxlist.com/effexor-xr-drug-summary.htm
[4] https://www.drugpatentwatch.com/
[5] https://www.mayoclinic.org/diseases-conditions/depression/in-depth/antidepressants/art-20044970